Skip to main content
Radiation Protection Dosimetry logoLink to Radiation Protection Dosimetry
. 2016 Jun 7;169(1-4):158–164. doi: 10.1093/rpd/ncw107

14C BOMB-PULSE DATING AND STABLE ISOTOPE ANALYSIS FOR GROWTH RATE AND DIETARY INFORMATION IN BREAST CANCER?

K Lång 1,*,, K Eriksson Stenström 2,, A Rosso 3, M Bech 4, S Zackrisson 1, D Graubau 5, S Mattsson 6
PMCID: PMC4911969  PMID: 27179119

Abstract

The purpose of this study was to perform an initial investigation of the possibility to determine breast cancer growth rate with 14C bomb-pulse dating. Tissues from 11 breast cancers, diagnosed in 1983, were retrieved from a regional biobank. The estimated average age of the majority of the samples overlapped the year of collection (1983) within 3σ. Thus, this first study of tumour tissue has not yet demonstrated that 14C bomb-pulse dating can obtain information on the growth of breast cancer. However, with further refinement, involving extraction of cell types and components, there is a possibility that fundamental knowledge of tumour biology might still be gained by the bomb-pulse technique. Additionally, δ 13C and δ 15N analyses were performed to obtain dietary and metabolic information, and to serve as a base for improvement of the age determination.

INTRODUCTION

Large amounts of the radioactive carbon isotope 14C were produced during atmospheric testing of nuclear weapons in the late 1950s and early 1960s. As a consequence, the concentration of 14C in air was almost doubled by 1963. Since the 14C produced was incorporated in atmospheric CO2 and introduced into the global carbon cycle, all organisms living during the bomb-pulse era, including humans, have been labelled with bomb-14C(13). When the Limited Test Ban Treaty from 1963 was implemented, the atmospheric 14C concentration commenced decreasing mainly due to uptake of 14CO2 into the oceans and also into the biosphere (see Figure 1).

Figure 1.

Figure 1.

14C specific activity in atmospheric CO2 and oceans representative for the northern hemisphere (expressed in units of Fraction Modern, F14C(4); F14C is ~1.0 before the nuclear weapons tests, corresponding to the natural 14C/12C ratio of about 10−10%(57)).

Already in the early 1970s, Harkness and Walton(8) realised the potential of using bomb-14C as a kinetic tracer in humans. Since then, the well-known decreasing atmospheric 14C concentration has provided useful information in several fields in the medical sciences, see e.g. Falso and Buchholz(9) and Spalding et al. (10). For instance, this so called 14C bomb pulse has served in studies of turnover rates in human cells and tissues (e.g. in eye lenses(11), fat cells(12) and Achilles tendon(13)). The development of various diseases has also been investigated using the 14C bomb-pulse technique, with 14C measurements on e.g. gallstones(14) and Alzheimer plaques(15). A common denominator for these studies is slow turnover (years). Another example is Gonçalves et al. (16), who demonstrated that human atherosclerotic plaques, known to cause e.g. heart attacks and strokes, develop slowly (mean biological ages 5–15 years). Quantification of the age of various structures in the plaque has gained a better understanding of the development of the plaque and opened for improved treatment methods.

The bomb-pulse technique has to the present authors’ knowledge not yet been used to study cancer. Understanding of the time cause for the development of human cancer tissue is of utmost importance for improved prevention and treatment strategies. So far, certain assumptions have had to be made in order to estimate how long a cancer has grown. There are theoretical models to describe tumour growth rates, such as an exponential growth model or the Gompertz Model, where the latter takes into consideration a slower growth rate as the tumour size increases. These models have been applied to cancer in general(17) and to breast cancer in particular(1820). These models have been shown to fit experimental and clinical data, such as observations of the doubling of tumour volume on serial mammograms. From these studies, the average tumour volume doubling time for human breast cancer has been estimated to be between 105 and 327 days(2129). Theoretically, this means that a breast cancer that is 10-mm large at detection (30 volume doublings) has been growing for 9–27 years. However, these studies are limited due to the lack of direct observations of tumour age.

The main purpose of this study was to perform an initial investigation of the possibility to determine the growth rate of breast cancer with 14C bomb-pulse dating. An additional aim was to highlight the limitations of the 14C bomb-pulse technique of human tissues due to dietary variations. Furthermore, the paper pays attention to how dietary information can be obtained from stable isotope ratio analysis of carbon and nitrogen, also providing means to increase the accuracy of bomb-pulse dating. Stable isotope ratio analysis may also give important information relating cancer development to diet.

Bomb-pulse dating and stable isotope analysis

The 14C bomb-pulse technique uses 14C data from atmospheric clean-air CO2 to translate the 14C specific activity of the sample into a calendar date (so called CaliBomb dates, see ‘Material and Methods’ section). For humans, carbon enters the body mainly through the diet. Thus, 14C data from clean-air CO2 may not be fully representative for humans.

A previous study by Georgiadou et al. (30) used human blood serum samples from a biobank to estimate the accuracy of bomb-pulse dating on human material. Blood serum samples collected from residents of Malmö (Sweden) in 1978 exhibited CaliBomb dates between 3.0 ± 0.4 years before the collection date and 0.2 ± 0.5 years after the collection date (the average deviation from collection date was −1.5 ± 0.7 years). Two major effects associated with the age deviation, competing in opposite directions, were identified: (1) delay time between production and consumption of foodstuffs, which can explain CaliBomb dates obtained before the collection date and (2) excessive consumption of marine food products, which has the potential of producing CaliBomb dates after the collection date.

As discussed in the study by Georgiadou et al. (30), there are also other factors that have the possibility to influence the obtained CaliBomb date, however, for the majority of the population probably to a more limited extent than delay time and marine food consumption. Anthropogenic 14C released from nuclear power plants or from research laboratories, industry or hospitals using 14C as a tracer has the potential of producing too old CaliBomb dates (at the declining bomb-pulse curve)(31, 32). On the other hand, fossil fuel-based products in food industry (e.g. in CO2 used in cultivation in greenhouses) as well as food grown in heavily industrialised areas may lead to foodstuffs having lower 14C specific activity than clean air, thus contributing to producing too young CaliBomb dates (at the declining bomb-pulse curve)(33).

14C bomb-pulse dates reported in the literature usually do not take into account that there is a delay time between production and consumption of the food(33, 34). Neither is it commonly considered that marine foodstuffs can influence the accuracy of the calibration (see the difference in marine and atmospheric calibration curve in Figure 1). However, since a large consumption of marine foodstuffs has the potential to affect the calibration curve (see Figure 1) on an individual basis, information about the diet may be important in bomb-pulse dating of human tissue samples. Additionally, the individual diet is of interest for studies of the development of various diseases, including breast cancer(35).

One technique to assess the diet of an organism is analysis of the ratios of stable isotopes of carbon and nitrogen (expressed as δ 13C and δ 15N in ‰, where δX = [(Rsample/Rstandard) − 1] × 1000, and R is the ratio of heavy to light isotope, i.e.13C/12C or 15N/14N) (see e.g. Schoeller(36)). δ 13C and δ 15N provide dietary information since the stable isotope ratios in tissues and organs of the consumer reflect those of the diet with a small shift. This discrimination of one of the stable isotopes occurs in each step of the food chain. The difference in δ-value between an organism and its diet, referred to as the discrimination factor, is generally about 1‰ for δ 13C and 3‰ for δ 15N(37). The discrimination factor, however, also depends on various factors such as species, age, metabolic processes and environmental conditions (see e.g. Caut et al. (37) and O’Connell et al. (38)). Thus, different trophic levels (positions in the food chain) are characterised by different ranges of δ values (see Figure 2).

Figure 2.

Figure 2.

Generalised isotopic trophic level diagram for terrestrial and marine food webs (values from Georgiadou et al. (30)). The δ 13C values of C3 plants (e.g. wheat and potatoes) differ from those of C4 plants (e.g. maize and sugar cane) due to photosynthetic pathways. For the Swedish diet, of relevance for this study, C3 plants dominate over C4 plants.

Despite the complexity and variation of discrimination factors, several studies have shown that δ 13C and δ 15N are valuable biomarkers of dietary intake (see e.g. Georgiadou et al. (30) and Patel et al. (39) and references therein). The approach can additionally be used as a tool to identify samples where extreme dietary conditions (high intake of marine products) might influence the 14C bomb-pulse date (decreasing the applicability of the atmospheric calibration curve).

The serum study(30) showed that the age deviation (difference between CaliBomb date and actual sampling date) correlated strongly with δ 13C, which was interpreted as influence from marine dietary components. δ 15N, however, did not show any correlation with age deviation in that study. δ 13C data from the serum study have also been used to demonstrate the possibility to develop general methods increasing accuracy as well as precision of the age determination using the 14C bomb-pulse technique(40). However, more data are needed to produce a general correction model.

MATERIAL AND METHODS

Frozen breast cancer tissues from 11 women collected in 1983 were retrieved from the South Swedish Breast Cancer Group Biobank. In three cases, the samples were large and sub-samples from each tumour could be taken (maximum of three sub-samples per cancer).

Prior to 14C analysis, parts of each tissue sample were graphitised according to the procedures described by Andersson Georgiadou et al. (41) and Genberg et al. (42). Total carbon in the graphite samples ranged between 32 and 124 µg. The 14C/C ratio, expressed as F14C(4), was analysed with accelerator mass spectrometry (AMS) at the Lund Single Stage AMS facility at Lund University(43, 44). The analytical precision of the F14C measurements for human tissue samples is usually 0.5–1% for this instrument(40). The obtained F14C values were translated into calendar years using the CaliBomb software (http://calib.qub.ac.uk/CALIBomb/), choosing the calibration dataset ‘Levin’ (representative for European clean-air CO2) and ‘smoothing’ (averaging the dataset) of 0.5 years. A given analytical uncertainty in F14C results in various uncertainties in the CaliBomb date depending e.g. on the steepness of the declining bomb-pulse curve and on seasonal variations (see Figure 1).

δ 13C and δ 15N were analysed using isotope ratio mass spectrometry (IRMS) at the Department of Biology, Lund University, using between 0.28 and 0.40 mg of dried tumour material for each sample. The analytical precision obtained for standards at this instrument is usually <0.4‰ for carbon and <0.12‰ for nitrogen (1σ). Further information about the IRMS analysis can be found in Andersson Georgiadou(40).

RESULTS AND DISCUSSION

The results of the 14C measurements and the IRMS analysis are shown in Table 1. A few samples lack IRMS data due to insufficient amount of sample material. The analytical uncertainties of the 14C measurements were higher than normally because of the difficulty of accurately weighing the samples and due to smaller and more varying sample sizes than usually.

Table 1.

Results from the 14C and IRMS analyses of the breast tumour samples.

Sample Year of birth Lab code 14C analysis IRMS analysis
m C (µg) F14C ± 1σ CaliBomb date ± 1σ m (mg) δ 13C (‰) δ 15N (‰)
T1 1924 GEO_1511 45 1.211 ± 0.014 1984.8 ± 1.1 0.30 −22.3 11.0
T2 1901 GEO_1512 56 1.193 ± 0.013 1986.2 ± 1.9 0.30 −22.0 11.7
T3A 1928 GEO_1513 130 1.309 ± 0.015 1979.3 ± 0.6 0.35 −22.5 13.3
T3B GEO_1514 63 1.241 ± 0.014 1982.8 ± 0.9 0.28 −22.7 12.8
T3C GEO_1515 88 1.240 ± 0.014 1982.9 ± 0.9
T4 1919 GEO_1516 54 1.239 ± 0.014 1982.9 ± 0.9
T5 1922 GEO_1517 53 1.222 ± 0.014 1984.1 ± 0.8 0.39 −21.2 13.2
T6 1901 GEO_1518 124 1.244 ± 0.014 1982.7 ± 0.9 0.37 −21.0 13.0
T6:2 GEO_1519 103 1.232 ± 0.014 1983.1 ± 0.8
T7 1898 GEO_1520 83 1.274 ± 0.014 1980.9 ± 1.0 0.32 −27.3 9.3
T8 1932 GEO_1521 101 1.247 ± 0.014 1982.3 ± 1.3 0.40 −23.3 11.0
T9A 1902 GEO_1522 52 1.184 ± 0.013 1987.5 ± 1.7 0.35 −22.8 9.4
T9B GEO_1523 37 1.190 ± 0.013 1986.7 ± 1.7 0.28 −24.7 7.8
T9C GEO_1524 32 1.157 ± 0.013 1990.2 ± 1.7
T10 1915 GEO_1525 98 1.137 ± 0.013 1992.8 ± 3.3 0.37 −20.6 13.7
T11 1911 GEO_1526 79 1.223 ± 0.014 1984.1 ± 0.7 0.32 −21.9 10.3

All samples were collected in 1983. Only results from the time after the bomb-pulse peak in 1963 are shown. A few samples lack IRMS data due to insufficient amount of sample material (m means mass of carbon (m C (ug)) and sample (m (mg)), respectively).

Table 1 only includes CaliBomb dates after the peak in 1963 (all calibrations also return a result between the mid-1950s and beginning of the 1960s). It is however not likely that the results from the rising part of the bomb-pulse curve are relevant in this study. A result from the rise of the bomb pulse would imply that the carbon in the analysed tissue was about 20 years old at the time of collection for all the subjects (not likely, the subjects were between about 30 and 60 years of age in the late 1950s). Another alternative would be that the turnover of cells is very slow resulting in an average F14C value corresponding to the rise of the bomb pulse. Neither this explanation appears likely. The most plausible explanation seems to be that the carbon in the breast tumour samples mainly originates from recently consumed food.

Figure 3 shows the results from the 14C measurements (±1σ, results only for the declining part of the bomb-pulse curve) for each subject (the year of collection was 1983). The CaliBomb date of all samples except T3A and T9C overlaps with the year of collection 1983 within 3σ.

Figure 3.

Figure 3.

Results from the 14C measurements (±1σ) for each subject (the year of collection, 1983, is indicated in grey).

Figure 4 shows the δ 13C and δ 15N values obtained for the tumour samples. Sample T7 seems to lie apart from rest of the samples. In contrast to the other samples, T7 contained mainly fat tissue, alternatively necrosis, which might explain the separate location of the samples in the diagram. In stable isotope analysis of human tissues, it is also known that different tissues do not have identical δ 13C and δ 15N values (see e.g. Caut et al. (37) and Tieszen et al. (45)). Fatty acids, e.g., are known to be depleted in δ 13C (having a negative discrimination factor) compared to other tissues as well as diet. Schoeller et al. (46) found that δ 13C(plasma lipid) < δ 13C(plasma protein) in 10 American subjects. Tieszen et al. (45) report that δ 13C values in gerbil were ranked as fat < liver < muscle < brain < hair (the discrimination factor between diet and fat being about −3‰). The present results for sample T7 follow the same trend as these observations and indicate that δ 13C(fat cells/fat tissue) < δ 13C(cancer cells).

Figure 4.

Figure 4.

δ 13C and δ 15N obtained for the tumour samples (compare with Figure 2). A few tumour samples lack IRMS data due to insufficient amount of sample material.

Figure 5 shows the δ 13C and δ 15N values obtained for the tumour samples including previous measurements of serum and atherosclerotic plaques from Swedish patients (see Gonçalves et al.(47)). It should be noted that the subjects are not the same, neither is the year of collection (serum from 1978 and plaque from 2007–2009). However, in this diagram sample T7 still lies apart from the rest of all sample types. Figure 5 also indicates linear correlations between δ 13C and δ 15N for the various sample types. This can be expected considering the tropic level diagram in Figure 2.

Figure 5.

Figure 5.

δ 13C and δ 15N for the tumour samples and previous measurements on Swedish plaque(41) and serum(30). Note that serum for the omnivores, in general, has higher δ 13C and δ 15N than vegans and lacto-ovo vegetarians (l-o-veg), in concordance with the generalised isotopic trophic diagram in Figure 2.

The main purpose of the δ 13C and δ 15N measurements of the breast tumour samples was to evaluate if the diet of any of the subjects contained a large proportion of fish products, which could influence the 14C value (according to Figure 1). High values of both δ 13C and δ 15N (upper right corner of Figure 2) correspond to more fish products in the diet than low values (lower left corner of Figure 2). According to Figures 4 and 5, tumour samples with high δ 13C and δ 15N values (upper right corner) could indicate that these subjects consume more marine foodstuffs than the others (e.g. the diet of subjects 5, 6 and 10 contains more fish products than others). The excess marine influence could subsequently affect the bomb-pulse dating (see Figure 1), and possibly give dates after the collection date (above the grey area in Figure 3). This is not observed (see Figure 3). In view of the limited amount of samples, the magnitude of the uncertainty of the measurements, the variability of discrimination factors and probably variability in growth rate of breast tumours, it is difficult to draw any general conclusions from the findings.

It is evident that further development of the application of 14C bomb-pulse dating technique for breast cancer research is needed before it can be of use. A main drawback of the technique is that the 14C content in the tumour tissue originating from the time when the tumour was in its initial stage is small relative to the 14C content from the later created part of the tumour. Analysis of extracted tumour DNA may be a way to obtain more relevant growth rate information, since 50% of carbon in DNA originates from the latest cell division(9). A better approach to estimate the onset of the tumour growth would be to isolate and analyse cancer stem cell DNA. The main challenge of this approach will be to obtain samples large enough for the 14C analysis (at least 10 µg of carbon is required for the system used). An associated difficulty is that the slope of the bomb pulse nowadays is approaching zero. This means that the resulting uncertainty in the age determination increases to inapplicability when approaching present days. Thus bomb-pulse dating of fresh material is only possible for cells or tissues with a slow turnover (several years). For materials with shorter turnover, relevant age information can only be obtained from the steeper part of the bomb-pulse curve, and biological material from biobanks must be used. The available amounts of sample material in the biobanks are however often very limited.

If the estimate of the 14C turnover rate can be more exact, the information gained can be of value, primarily in the understanding of tumour biology: which is the tumour growth rate? Also, the clinical implications of the dating of breast cancer could be the revision or validation of existing tumour growth models. Furthermore, in breast cancer screening one major drawback is the overdiagnosis of slow-growing indolent tumours. Overdiagnosis occurs when women without symptoms are diagnosed with a disease that will not cause them to experience symptoms or lead to early death(48). It has been estimated that the overdiagnosis in breast cancer screening is 10–20%(49, 50). It is not possible to incorporate 14C bomb-pulse dating in clinical practice since the method is both laborious and expensive and most importantly the atmospheric levels of 14C are now down at a low level. That is why the 14C bomb-pulse dating technique applied on breast cancer combined with an analysis of micro- and macro-structural changes in the tumour, in order to find a signature of a slow growing cancer, could be of interest. For example, in parallel to the efforts of obtaining relevant tumour growth rate information, samples of the same breast tumour could be investigated with a high-resolution imaging technique, i.e. synchrotron radiation-based small angle X-ray scattering to detect changes in the collagen structure of the tumour tissue(51). If structural changes in a breast tumour can be correlated to growth rate, this could provide means to find new biomarkers or a morphological signature that can be used to further refine breast cancer diagnosis and ultimately optimise the treatment, e.g. less aggressive treatment of indolent tumours.

CONCLUSIONS

This is a first pilot study assessing the potential of carbon and nitrogen isotope analysis for obtaining growth rate (14C/12C) and dietary (13C/12C and 15N/14N) information for breast cancer research. Stable carbon and nitrogen isotope analysis may give information about the relation between diet and breast cancer development and progression.

The measurements in this limited, initial study could not demonstrate the possibility to obtain age information on the onset of the breast cancer. However, analysis of total tumour material may primarily reflect the current turnover of the carbon in the various components of the metabolically active tumour tissue. Analysis of extracted tumour DNA, or the isolation and analysis of cancer stem cells, may be a way to obtain more relevant growth rate and age information. Furthermore, 13C/12C and 5N/14N analysis may provide important dietary information of value for studies of possible correlations between diet and tumour development.

ACKNOWLEDGEMENTS

Mattias Olsson at Geocentrum, Lund University, is acknowledged for his help with the sample preparations prior to IRMS and AMS measurements.

FUNDING

This work was supported by Stiftelsen Hedda och John Forssmans fond [2014/12 to K.L.]; the Nils-Magnus och Irma Ohlssons stiftelse för vetenskaplig forskning och utbildning [2015/03 to K.L.] and Stiftelsen för cancerforskning vid Onkologiska kliniken vid Universitetssjukhuset MAS [2014/11 to K.L.].

REFERENCES

  • 1.Libby W. F., Berger R., Mead J. F., Alexander G. V. and Ross J. F.. Replacement rates for human tissue from atmospheric radiocarbon. Science 146, 1170–1172 (1964). [DOI] [PubMed] [Google Scholar]
  • 2.Broecker W. S., Schulert A. and Olson E. A.. Bomb carbon-14 in human beings. Science 130, 331–332 (1959). [DOI] [PubMed] [Google Scholar]
  • 3.Harkness D. D. and Walton A.. Carbon-14 in the biosphere and humans. Nature 223, 1216–1218 (1969). [DOI] [PubMed] [Google Scholar]
  • 4.Reimer P. J., Brown T. A. and Reimer R. W.. Discussion: reporting and calibration of post-bomb 14C data. Radiocarbon 46, 1299–1304 (2004). [Google Scholar]
  • 5.Levin I. and Kromer B.. The tropospheric 14CO2 level in mid latitudes of the northern hemisphere (1959–2003). Radiocarbon 46, 1261–1271 (2004). [Google Scholar]
  • 6.Levin I., Kromer B. and Hammer S.. Atmospheric Δ14CO2 trend in Western European background air from 2000 to 2012. Tellus B 65, 20092 (2013). [Google Scholar]
  • 7.Kalish J., Nydal R., Nedreaas K., Burr G. and Eine G.. A time history of pre- and post-bomb radiocarbon in the Barents sea derived from Arcto-Norwegian cod otoliths. Radiocarbon 43, 843–845 (2001). [Google Scholar]
  • 8.Harkness D. D. and Walton A.. Further investigations of the transfer of bomb 14C to man. Nature 240, 302–303 (1972). [DOI] [PubMed] [Google Scholar]
  • 9.Falso M. J. S. and Buchholz B. A.. Bomb pulse biology. Nucl. Instr. Meth. B 294, 666–670 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Spalding K. L., Bhardwaj R. D., Buchholz B. A., Druid H. and Frisen J.. Retrospective birth dating of cells in humans. Cell 122, 133–143 (2005). [DOI] [PubMed] [Google Scholar]
  • 11.Lynnerup N., Kjeldsen H., Heegaard S., Jacobsen C. and Heinemeier J.. Radiocarbon dating of the human eye lens crystallines reveal proteins without carbon turnover throughout life. PLoS One 3, e1529 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Spalding K. L., et al. Dynamics of fat cell turnover in humans. Nature 453, 783–787 (2008). [DOI] [PubMed] [Google Scholar]
  • 13.Heinemeier K. M., Schjerling P., Heinemeier J., Magnusson S. P. and Kjaer M.. Lack of tissue renewal in human adult achilles tendon is revealed by nuclear bomb 14C. FASEB J. 27, 2074–2079 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Druffel E. M. and Mok H. I.. Time history of human gallstones: application of the post-bomb radiocarbon signal. Radiocarbon 25, 629–636 (1983). [Google Scholar]
  • 15.Lovell M. A., Robertson J. D., Buchholz B. A., Xie C. and Markesbery W. R.. Use of bomb pulse carbon-14 to age senile plaques and neurofibrillary tangles in Alzheimer’s disease. Neurobiol. Aging 23, 179–186 (2002). [DOI] [PubMed] [Google Scholar]
  • 16.Gonçalves I., Stenström K., Skog G., Mattsson S., Nitulescu M. and Nilsson J.. Short communication: dating components of human atherosclerotic plaques. Circ. Res. 106, 1174–1177 (2010). [DOI] [PubMed] [Google Scholar]
  • 17.Laird A. K. Dynamics of tumour growth. Br. J. Cancer 18, 490–502 (1964). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hart D., Shochat E. and Agur Z.. The growth law of primary breast cancer as inferred from mammography screening trials data. Br. J. Cancer 78, 382–387 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Spratt J. A., von Fournier D., Spratt J. S. and Weber E. E.. Decelerating growth and human breast cancer. Cancer 71, 2013–2019 (1993). [DOI] [PubMed] [Google Scholar]
  • 20.Norton L. A Gompertzian model of human breast cancer growth. Cancer Res. 48, 7067–7071 (1988). [PubMed] [Google Scholar]
  • 21.Schwartz M. A biomathematical approach to clinical tumor growth. Cancer 14, 1272–1294 (1961). [DOI] [PubMed] [Google Scholar]
  • 22.Fournier D. V., Weber E., Hoeffken W., Bauer M., Kubli F. and Barth V.. Growth rate of 147 mammary carcinomas. Cancer 45, 2198–2207 (1980). [DOI] [PubMed] [Google Scholar]
  • 23.Spratt J. A., von Fournier D., Spratt J. S. and Weber E. E.. Mammographic assessment of human breast cancer growth and duration. Cancer 71, 2020–2026 (1993). [DOI] [PubMed] [Google Scholar]
  • 24.Lundgren B. Observations on growth rate of breast carcinomas and its possible implications for lead time. Cancer 40, 1722–1725 (1977). [DOI] [PubMed] [Google Scholar]
  • 25.Heuser L., Spratt J. S. and Polk H. C.. Growth rates of primary breast cancers. Cancer 43, 1888–1894 (1979). [DOI] [PubMed] [Google Scholar]
  • 26.Peer P. G. M., van Dijck J. A. A. M., Hendriks J. H. C. L., Holland R. and Verbeek A. L. M.. Age-dependent growth rate of primary breast cancer. Cancer 71, 3547–3551 (1993). [DOI] [PubMed] [Google Scholar]
  • 27.Kusama S., Spratt J. S., Donegan W. L., Watson F. R. and Cunningham C.. The gross rates of growth of human mammary carcinoma. Cancer 30, 594–599 (1972). [DOI] [PubMed] [Google Scholar]
  • 28.Spratt J. S., Heuser L., Kuhns J. G., Reiman H. M., Buchanan J. B., Polk H. C. and Sandoz J.. Association between the actual doubling times of primary breast cancer with histopathologic characteristics and Wolfe’s parenchymal mammographic patterns. Cancer 47, 2265–2268 (1981). [DOI] [PubMed] [Google Scholar]
  • 29.Kuroishi T., et al. Tumor growth rate and prognosis of breast cancer mainly detected by mass screening. Jpn J. Cancer Res. 81, 454–462 (1990). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Georgiadou E., Stenstrom K. E., Uvo C. B., Nilsson P., Skog G. and Mattsson S.. Bomb-pulse 14C analysis combined with 13C and 15N measurements in blood serum from residents of Malmö, Sweden. Radiat. Environ. Biophys. 52, 175–187 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Stenström K., Leide-Svegborn S. and Mattsson S.. Low-level occupational 14C contamination – results from a pilot study. Radiat. Prot. Dosim. 130, 337–342 (2008). [DOI] [PubMed] [Google Scholar]
  • 32.Stenström K., Unkel I., Nilsson C. M., Rääf C. and Mattsson S.. The use of hair as an indicator of occupational 14C contamination. Radiat. Environ. Biophys. 49, 97–107 (2010). [DOI] [PubMed] [Google Scholar]
  • 33.Stenström K., Skog G., Nilsson C. M., Hellborg R., Svegborn S. L., Georgiadou E. and Mattsson S.. Local variations in 14C – how is bomb-pulse dating of human tissues and cells affected. Nucl. Instr. Meth. B 268, 1299–1302 (2010). [Google Scholar]
  • 34.Georgiadou E. and Stenström K.. Bomb-pulse dating of human material – modelling the influence of diet. Radiocarbon 52, 1351–1357 (2010). [Google Scholar]
  • 35.Rossi R. E., Pericleous M., Mandair D., Whyand T. and Caplin M. E.. The role of dietary factors in prevention and progression of breast cancer. Anticancer Res. 34, 6861–6875 (2014). [PubMed] [Google Scholar]
  • 36.Schoeller D. A. Isotope fractionation: Why aren’t we what we eat. J. Arch. Sci. 26, 667–673 (1999). [Google Scholar]
  • 37.Caut S., Angulo E. and Courchamp F.. Discrimination factors (δ15N and δ13C) in an omnivorous consumer: effect of diet isotopic ratio. Funct. Ecol. 22, 255–263 (2008). [Google Scholar]
  • 38.O’Connell T. C., Kneale C. J., Tasevska N. and Kuhnle G. G. C.. The diet-body offset in human nitrogen isotopic values: a controlled dietary study. Am. J. Phys. Anthr. 149, 426–434 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Patel P. S., et al. Serum carbon and nitrogen stable isotopes as potential biomarkers of dietary intake and their relation with incident type 2 diabetes: the Epic-Norfolk study. Am. J. Clin. Nutr. 100, 708–718 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Andersson Georgiadou E. Exploring the possibilities of 14C bomb-pulse dating of human tissue samples Ph.D. thesis, Lund University (2014). ISBN 978-91-7623-023-0.
  • 41.Andersson Georgiadou E., Gonçalves I., Bertacchi Uvo C., Nilsson J., Skog G., Mattsson S., Mendes Pedro L., Fernades e Fernandes J. and Eriksson Stenström K.. Potential influence of diet on bomb-pulse dating of human plaque samples. Radiocarbon 55, 874–884 (2013). [Google Scholar]
  • 42.Genberg J., Stenström K., Elfman M. and Olsson M.. Development of graphitization of μg-sized samples at Lund University. Radiocarbon 52, 1270–1276 (2010). [Google Scholar]
  • 43.Skog G. The single stage AMS machine at Lund University: status report. Nucl. Instr. Meth. B 259, 1–6 (2007). [Google Scholar]
  • 44.Skog G., Rundgren M. and Sköld P.. Status of the single stage AMS machine at Lund University after 4 years of operation. Nucl. Instr. Meth. B 268, 895–897 (2010). [Google Scholar]
  • 45.Tieszen L. L., Boutton T. W., Tesdahl K. G. and Slade N. A.. Fractionation and turnover of stable carbon isotopes in animal tissues: implications for δ13C analysis of diet. Oecologia 57, 32–37 (1983). [DOI] [PubMed] [Google Scholar]
  • 46.Schoeller D. A., Minagawa M., Slater R. and Kaplan I. R.. Stable isotopes of carbon, nitrogen and hydrogen in the contemporary North American human food web. Ecol. Food Nutr. 18, 159–170 (1986). [Google Scholar]
  • 47.Gonçalves I., Andersson Georgiadou E., Mattsson S., Skog G., Pedro L., Fernandes e Fernandes J., Dias N., Engström G., Nilsson J. and Stenström K.. Direct association between diet and the stability of human atherosclerotic plaque. Scientific Reports 5, 15524 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Moynihan R., Doust J. and Henry D.. Preventing overdiagnosis: how to stop harming the healthy. Br. Med. J. 344, e3502 (2012). [DOI] [PubMed] [Google Scholar]
  • 49.Zackrisson S., Andersson I., Janzon L., Manjer J. and Garne J. P.. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. Br. Med. J. 332, 689–692 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Independent UK Panel on Breast Cancer Screening The benefits and harms of breast cancer screening: an independent review. Lancet 380(9855), 1778–1786 (2012). [DOI] [PubMed] [Google Scholar]
  • 51.Keyriläinen J., Bravin A., Fernández M., Tenhunen M., Virkkunen P. and Suortti P.. Phase-contrast X-ray imaging of breast. Acta Radiol. 51, 866–884 (2010). [DOI] [PubMed] [Google Scholar]

Articles from Radiation Protection Dosimetry are provided here courtesy of Oxford University Press

RESOURCES